CRISPR, AI, and Pharma’s New Alliances
Kilder
- Fierce Biotech: Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model - Fierce Biotech
- BioSpace: BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival - BioSpace
- Raps: Recon: Makary to resign as FDA commissioner; EU reaches draft deal on Critical Medicines Act - RAPS.org
- STAT: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs - statnews.com
- Fierce Biotech: BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed - Fierce Biotech
- BioSpace: BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal - BioSpace
- Bioworld: Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal - BioWorld News
- BioPharma Dive: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug - BioPharma Dive
- Firstwordpharma: Biopharma bites: Rigel buys beleaguered PROTAC, Bayer's pipeline trim, and more from Novo Nordisk, Delos Capital - FirstWord Pharma
- Bioworld: MHRA sets out proposal to redefine gene therapies - BioWorld News
- Bioworld: MHRA sets out proposal to redefine gene therapies - BioWorld News
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.